Studies on Asthma / COPD / Allergy
CRS has all sorts of experience from conducting more than 60 trials in the past 8 years
Our clinical trial sites are equipped with digital spirometry, body plethysmography, diffusing capacity of lung for carbon monoxide (DLCO) measurement and ergospirometry. Our staff, with its broad clinical experience, has been involved in numerous early phase respiratory clinical trials and, thus, CRS is a reliable partner for your drug development.
INHALATION OF VARIOUS SUBSTANCES HAS A LONG TRADITION
Today, buccal, intranasal or intrapulmonal drug administration is of high interest for the specific treatment of certain diseases.
A buccal or intranasal drug application can be used when rapid absorption and avoidance of the first-pass metabolism are required – this might be relevant, e.g., for medications of hormones or analgesics.
INHALATION WAS EMPLOYED AS A METHOD OF DELIVERY MORE THAN A THOUSAND YEAR AGO.
Inhalation of a suitable drug can be deployed either, when the direct delivery to local mucosa is required for a regional effect, or when a fast systemic absorption over the capillary membrane of the